These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

473 related items for PubMed ID: 30217192

  • 1. AR-PDEF pathway promotes tumour proliferation and upregulates MYC-mediated gene transcription by promoting MAD1 degradation in ER-negative breast cancer.
    Cao L, Xu C, Xiang G, Liu F, Liu X, Li C, Liu J, Meng Q, Jiao J, Niu Y.
    Mol Cancer; 2018 Sep 14; 17(1):136. PubMed ID: 30217192
    [Abstract] [Full Text] [Related]

  • 2. Clinical significance of PDEF factor expression and its relation to androgen receptor in ER- breast cancer.
    Cao L, Li C, Xu C, Xiang G, Liu F, Liu X, Jiao J, Lv S, Niu Y.
    Histopathology; 2018 Nov 14; 73(5):819-831. PubMed ID: 29969155
    [Abstract] [Full Text] [Related]

  • 3. Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells.
    Tsui KH, Chung LC, Feng TH, Chang PL, Juang HH.
    Int J Cancer; 2012 Jun 15; 130(12):2812-23. PubMed ID: 21780100
    [Abstract] [Full Text] [Related]

  • 4. Lin28A activates androgen receptor via regulation of c-myc and promotes malignancy of ER-/Her2+ breast cancer.
    Shen H, Zhao L, Feng X, Xu C, Li C, Niu Y.
    Oncotarget; 2016 Sep 13; 7(37):60407-60418. PubMed ID: 27494865
    [Abstract] [Full Text] [Related]

  • 5. A high AR:ERα or PDEF:ERα ratio predicts a sub-optimal response to tamoxifen therapy in ERα-positive breast cancer.
    Cao L, Xiang G, Liu F, Xu C, Liu J, Meng Q, Lyu S, Wang S, Niu Y.
    Cancer Chemother Pharmacol; 2019 Sep 13; 84(3):609-620. PubMed ID: 31297554
    [Abstract] [Full Text] [Related]

  • 6. Androgen receptor decreases CMYC and KRAS expression by upregulating let-7a expression in ER-, PR-, AR+ breast cancer.
    Lyu S, Yu Q, Ying G, Wang S, Wang Y, Zhang J, Niu Y.
    Int J Oncol; 2014 Jan 13; 44(1):229-37. PubMed ID: 24172884
    [Abstract] [Full Text] [Related]

  • 7. Androgen Receptor Expression and Bicalutamide Antagonize Androgen Receptor Inhibit β-Catenin Transcription Complex in Estrogen Receptor-Negative Breast Cancer.
    Huang R, Han J, Liang X, Sun S, Jiang Y, Xia B, Niu M, Li D, Zhang J, Wang S, Wei W, Liu Q, Zheng W, Zhang G, Song Y, Panga D.
    Cell Physiol Biochem; 2017 Jan 13; 43(6):2212-2225. PubMed ID: 29069648
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prostate-derived Ets transcription factor overexpression is associated with nodal metastasis and hormone receptor positivity in invasive breast cancer.
    Turcotte S, Forget MA, Beauseigle D, Nassif E, Lapointe R.
    Neoplasia; 2007 Oct 13; 9(10):788-96. PubMed ID: 17971898
    [Abstract] [Full Text] [Related]

  • 10. Androgen Triggers the Pro-Migratory CXCL12/CXCR4 Axis in AR-Positive Breast Cancer Cell Lines: Underlying Mechanism and Possible Implications for the Use of Aromatase Inhibitors in Breast Cancer.
    Azariadis K, Kiagiadaki F, Pelekanou V, Bempi V, Alexakis K, Kampa M, Tsapis A, Castanas E, Notas G.
    Cell Physiol Biochem; 2017 Oct 13; 44(1):66-84. PubMed ID: 29131020
    [Abstract] [Full Text] [Related]

  • 11. Prostate derived Ets transcription factor and Carcinoembryonic antigen related cell adhesion molecule 6 constitute a highly active oncogenic axis in breast cancer.
    Mukhopadhyay A, Khoury T, Stein L, Shrikant P, Sood AK.
    Oncotarget; 2013 Apr 13; 4(4):610-21. PubMed ID: 23592399
    [Abstract] [Full Text] [Related]

  • 12. Prostate-derived ets factor represses tumorigenesis and modulates epithelial-to-mesenchymal transition in bladder carcinoma cells.
    Tsui KH, Lin YH, Chung LC, Chuang ST, Feng TH, Chiang KC, Chang PL, Yeh CJ, Juang HH.
    Cancer Lett; 2016 May 28; 375(1):142-151. PubMed ID: 26965996
    [Abstract] [Full Text] [Related]

  • 13. Prostate derived ETS factor (PDEF): a putative tumor metastasis suppressor.
    Steffan JJ, Koul HK.
    Cancer Lett; 2011 Nov 01; 310(1):109-17. PubMed ID: 21764212
    [Abstract] [Full Text] [Related]

  • 14. PDEF promotes luminal differentiation and acts as a survival factor for ER-positive breast cancer cells.
    Buchwalter G, Hickey MM, Cromer A, Selfors LM, Gunawardane RN, Frishman J, Jeselsohn R, Lim E, Chi D, Fu X, Schiff R, Brown M, Brugge JS.
    Cancer Cell; 2013 Jun 10; 23(6):753-67. PubMed ID: 23764000
    [Abstract] [Full Text] [Related]

  • 15. KDM4B and KDM4A promote endometrial cancer progression by regulating androgen receptor, c-myc, and p27kip1.
    Qiu MT, Fan Q, Zhu Z, Kwan SY, Chen L, Chen JH, Ying ZL, Zhou Y, Gu W, Wang LH, Cheng WW, Zeng J, Wan XP, Mok SC, Wong KK, Bao W.
    Oncotarget; 2015 Oct 13; 6(31):31702-20. PubMed ID: 26397136
    [Abstract] [Full Text] [Related]

  • 16. Prostate-derived Ets transcription factor (PDEF) downregulates survivin expression and inhibits breast cancer cell growth in vitro and xenograft tumor formation in vivo.
    Ghadersohi A, Pan D, Fayazi Z, Hicks DG, Winston JS, Li F.
    Breast Cancer Res Treat; 2007 Mar 13; 102(1):19-30. PubMed ID: 16897429
    [Abstract] [Full Text] [Related]

  • 17. AR/ER Ratio Correlates with Expression of Proliferation Markers and with Distinct Subset of Breast Tumors.
    Rangel N, Rondon-Lagos M, Annaratone L, Aristizábal-Pachon AF, Cassoni P, Sapino A, Castellano I.
    Cells; 2020 Apr 24; 9(4):. PubMed ID: 32344660
    [Abstract] [Full Text] [Related]

  • 18. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
    Schlange T, Matsuda Y, Lienhard S, Huber A, Hynes NE.
    Breast Cancer Res; 2007 Apr 24; 9(5):R63. PubMed ID: 17897439
    [Abstract] [Full Text] [Related]

  • 19. Transcriptional regulation of p21/CIP1 cell cycle inhibitor by PDEF controls cell proliferation and mammary tumor progression.
    Schaefer JS, Sabherwal Y, Shi HY, Sriraman V, Richards J, Minella A, Turner DP, Watson DK, Zhang M.
    J Biol Chem; 2010 Apr 09; 285(15):11258-69. PubMed ID: 20139077
    [Abstract] [Full Text] [Related]

  • 20. Pdef expression in human breast cancer is correlated with invasive potential and altered gene expression.
    Feldman RJ, Sementchenko VI, Gayed M, Fraig MM, Watson DK.
    Cancer Res; 2003 Aug 01; 63(15):4626-31. PubMed ID: 12907642
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.